PZ Cormay S.A. (WSE:CRM)
0.5540
+0.0020 (0.36%)
May 13, 2025, 5:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Hematology | 37.44M |
Log In |
Log In |
Log In |
Log In |
Hematology Growth | -11.37% |
Log In |
Log In |
Log In |
Log In |
Biochemistry | 30.08M |
Log In |
Log In |
Log In |
Log In |
Biochemistry Growth | -2.90% |
Log In |
Log In |
Log In |
Log In |
Immunology | 7.24M |
Log In |
Log In |
Log In |
Log In |
Immunology Growth | 87.19% |
Log In |
Log In |
Log In |
Log In |
General Analytics | 1.53M |
Log In |
Log In |
Log In |
Log In |
General Analytics Growth | 27.95% |
Log In |
Log In |
Log In |
Log In |
Service | 1.09M |
Log In |
Log In |
Log In |
Log In |
Service Growth | 2.64% |
Log In |
Log In |
Log In |
Log In |
Coagulation | 829.00K |
Log In |
Log In |
Log In |
Log In |
Coagulation Growth | 2.85% |
Log In |
Log In |
Log In |
Log In |
Endomagnetics | 741.00K |
Log In |
Log In |
Log In |
Log In |
Vacutest | 614.00K |
Log In |
Log In |
Log In |
Log In |
Vacutest Growth | -0.49% |
Log In |
Log In |
Log In |
Log In |
Other | 2.67M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -30.19% |
Log In |
Log In |
Log In |
Log In |
COVID Diagnostics - 19 | - |
Log In |
Log In |
Log In |
Log In |
COVID Immunology - 19 | - |
Log In |
Log In |
Log In |
Log In |
COVID Immunology - 19 Growth | - |
Log In |
Log In |
Log In |
Log In |
Molecular Biology COVID-19 | - |
Log In |
Log In |
Log In |
Log In |
Other | 2.67M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -30.19% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Other | 32.69M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -7.93% |
Log In |
Log In |
Log In |
Log In |
Poland | 18.26M |
Log In |
Log In |
Log In |
Log In |
Poland Growth | 27.84% |
Log In |
Log In |
Log In |
Log In |
Russia | 12.64M |
Log In |
Log In |
Log In |
Log In |
Russia Growth | -23.34% |
Log In |
Log In |
Log In |
Log In |
Bangladesh | 3.76M |
Log In |
Log In |
Log In |
Log In |
Bangladesh Growth | -36.09% |
Log In |
Log In |
Log In |
Log In |
Ukraine | 3.66M |
Log In |
Log In |
Log In |
Log In |
Ukraine Growth | 38.95% |
Log In |
Log In |
Log In |
Log In |
Mexico | 3.04M |
Log In |
Log In |
Log In |
Log In |
Mexico Growth | 65.24% |
Log In |
Log In |
Log In |
Log In |
Panama | 2.32M |
Log In |
Log In |
Log In |
Log In |
Panama Growth | 16.78% |
Log In |
Log In |
Log In |
Log In |
Philippines | 2.01M |
Log In |
Log In |
Log In |
Log In |
Philippines Growth | -34.84% |
Log In |
Log In |
Log In |
Log In |
Saudi Arabia | 1.96M |
Log In |
Log In |
Log In |
Log In |
India | 1.89M |
Log In |
Log In |
Log In |
Log In |
India Growth | -3.32% |
Log In |
Log In |
Log In |
Log In |
Other | 32.69M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -7.93% |
Log In |
Log In |
Log In |
Log In |
Belarus | - |
Log In |
Log In |
Log In |
Log In |
Belarus Growth | - |
Log In |
Log In |
Log In |
Log In |
Iran | - |
Log In |
Log In |
Log In |
Log In |
Iran Growth | - |
Log In |
Log In |
Log In |
Log In |
Nigeria | - |
Log In |
Log In |
Log In |
Log In |
Nigeria Growth | - |
Log In |
Log In |
Log In |
Log In |
Switzerland | - |
Log In |
Log In |
Log In |
Log In |
Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In |
China | - |
Log In |
Log In |
Log In |
Log In |
China Growth | - |
Log In |
Log In |
Log In |
Log In |
Czech Republic | - |
Log In |
Log In |
Log In |
Log In |
Czech Republic Growth | - |
Log In |
Log In |
Log In |
Log In |